PRL and myeloid sarcoma: Despite QSM's diagnostic and prognostic potential, methodological heterogeneity and inconsistent standardization of PRL criteria limit comparability.<h4>Conclusion</h4>This review underscores QSM's utility as a biomarker for MS pathophysiology while advocating for standardized protocols and longitudinal studies to validate its clinical translation.